Old Articles: <Older 8321-8330 Newer> |
|
Pharmaceutical Executive May 1, 2012 |
Super-Size Me Finding opportunities in the information explosion: big data, big challenges and big rewards. |
Pharmaceutical Executive May 1, 2012 |
Managing Information Overload Pharmaceutical companies know they need regulatory information management. What they don't always know is where to start and how to weave this vital capability across the enterprise. |
Pharmaceutical Executive May 1, 2012 |
Pharma's Winning Innovative Technology Highlighting the pharmaceutical companies awarded for exemplifying a high level of operational excellence with technology. |
Pharmaceutical Executive May 1, 2012 |
Country Report: South Africa In just the past few years, South Africa has hit several key economic benchmarks demonstrating the country's upward trajectory. |
Pharmaceutical Executive May 1, 2012 Ben Comer |
Comparing Apples to Broccoli In late March, the Supreme Court debated the merits or lack thereof of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice? |
Pharmaceutical Executive May 1, 2012 |
Best Practices: Commercial Analytics If the relationship between marketers and commercial analytics in the pharmaceutical and biotech sectors is leveraged properly, it can help marketers make more informed strategic decisions for their brands. |
Pharmaceutical Executive May 1, 2012 |
Government: Big Pharma's Best Friend in Emerging Markets? To gain market access in emerging markets, pharma companies face pressure to offer a convincing Corporate Value Proposition to governments. |
Chemistry World May 8, 2012 Helen Carmichael |
Pharma firms see mixed fortunes in Quebec Quebec's life sciences and pharmaceutical industry has suffered several blows in 2012, with hundreds of R&D jobs being lost. This comes despite the industry receiving hundreds of millions of dollars in government assistance and favorable tax rates. |
Chemistry World May 4, 2012 Hayley Birch |
What to do with leftover prescription drugs? Throwing away unused medication is kinder to the environment than returning it to the pharmacy, according to a new study. |
Chemistry World May 3, 2012 Akshat Rathi |
Ranbaxy launches new anti-malarial Synriam It is the first recently developed antimalarial that is not based on artemisinin, one of the most effective treatments for malaria, which has begun to suffer from problems with resistance in recent years. |
<Older 8321-8330 Newer> Return to current articles. |